S
BNGO icon

SignatureFD’s Bionano Genomics BNGO Stock Holding History

SignatureFD’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7
Closed -$13K – 3149
2021
Q4 		$13K Sell
7
-10
-59% -$26.7K ﹤0.01% 1975
2021
Q3 		$55K Buy
17
+8
+89% +$28K ﹤0.01% 1254
2021
Q2 		$41K Hold
9
– – ﹤0.01% 1371
2021
Q1 		$45K Buy
+9
New +$50.7K ﹤0.01% 1213

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

SignatureFD's BNGO Position: Q1 2022 in Review

SignatureFD sold out of Bionano Genomics (BNGO) in Q1 2022, closing a stake of 7 shares — an estimated $13K sold.

SignatureFD first reported a position in BNGO in Q1 2021 and held it in 4 quarters. The position peaked at $55K in Q3 2021. 148 funds tracked by Wall St. Rank hold BNGO as of Q1 2022.

  • SignatureFD reported no remaining Bionano Genomics position as of Q1 2022 after selling out during the quarter.
  • SignatureFD sold 7 Bionano Genomics shares in Q1 2022, an estimated $13K.
  • SignatureFD first reported a position in Bionano Genomics in Q1 2021 and held it in 4 quarters.
  • SignatureFD's Bionano Genomics position peaked at $55K in Q3 2021.
  • 148 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2022.

Based on SignatureFD's 13F filing for Q1 2022, filed 2 May 2022.